Breckenridge Pharmaceutical, Inc. is recalling one lot of propranolol hydrochloride extended-release capsules, 60 mg, across the United States over possible metal contamination, in a notice the US Food and Drug Administration (FDA) published on 20 November 2026. The company first announced the consumer-level recall on 16 November.
Which product is being recalled?
The recall covers a single lot, PK25110035, of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, sold in 100-count bottles with the NDC number 51991-817-01 and an expiry date of May 2029, according to the company announcement posted by the FDA. The capsules were made by Adare Pharma Solutions and shipped to wholesalers and pharmacies nationwide between 26 October and 4 November 2026.
Propranolol is a beta-blocker widely prescribed for high blood pressure and other heart-related conditions.
What is the risk?
The company said metal contamination was found in a separate lot that was never released to the market. The recalled lot shared intermediate material with that batch, and this material is suspected to be the source of the contamination.
Taking capsules from the affected lot could potentially cause cuts to the soft tissues of the mouth, oesophagus, stomach or intestine, the notice said. Breckenridge said it is not aware of any adverse events assessed to be related to the recall.
What should patients do?
Patients should check the lot number on their bottle first. The company advises anyone holding capsules from lot PK25110035 to stop taking them, contact their doctor or healthcare provider for medical advice and replacement instructions, and return unused capsules to the pharmacy that dispensed them.
Wholesalers and pharmacies have been asked to check stock, quarantine the lot, stop dispensing it and alert any sub-accounts that received it. Questions about the recall go to Qualanex, Breckenridge's recall handler, on 1-855-736-0807 or recall@qualanex.com, Monday to Friday, 9 am to 5 pm US Eastern Time. Side effects can be reported to the FDA's MedWatch programme.
Does this affect Indian buyers?
The notice describes distribution within the United States only, and does not mention exports. Readers in India who buy medicines through US pharmacies or have family members in the US on this medicine may want to check the lot number. Breckenridge's media queries are handled by Towa International, its parent group, according to the notice.
Why it matters
Physical contaminants such as metal fragments are uncommon in finished medicines, and the case shows how a problem detected in one unreleased batch can trigger a recall of another batch made from shared material. The recall is limited to one lot; other propranolol strengths and lots are not covered by the notice.




